Clinical Updates

Drug approvals, guideline changes, and treatment advances

Monoclonal antibody cliramitug shows sustained benefit in cardiac amyloidosis over 29 months

Long-term follow-up of the NI006-101 trial shows that cliramitug, a monoclonal antibody targeting misfolded transthyretin, sustains clinical benefit in cardiac…

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.

More form Clinical Updates

How Coffee Brewing Method Affects Cholesterol: The Science Behind Diterpenes and Filters

Coffee's effect on cholesterol depends entirely on brewing method. Unfiltered coffee—French press, espresso, Turkish—allows diterpenes…

UK Health Security Agency Launches Evidence-Based Training Programme for Healthcare Staff

The UK Health Security Agency has launched a structured training programme to equip healthcare professionals…

UK Releases Rabies Post-Exposure Risk Assessment Tool for Clinical Practice

The UK Department of Health and Social Care has published a standardised rabies post-exposure risk…